Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-15 · accession 0001209191-23-046423 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-17 | 2023-08-15+ | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 875.7K | +9% | +$166.5K |
| DM | 2023-08-17 | 2023-08-15+ | RXRX | Secora Michael | CFO | S - Sale+OE | $9.09 | -50.0K | 850.7K | -6% | -$454.3K |
| D | 2023-08-17 | 2023-08-15 | RXRX | Secora Michael | CFO | F - Tax | $9.19 | -4,727 | 838.2K | -0.6% | -$43.4K |
| DM | 2023-08-17 | 2023-08-15+ | RXRX | Secora Michael | CFO | M - OptEx | $0.00 | -75.0K | 1.49M | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-08-16 | M | A | 37,500 | $2.22 | 888,186 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-08-16 | S | D | 25,000 | $8.90 | 863,186 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $8.66 to $9.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2023-08-15 | S | D | 25,000 | $9.27 | 850,686 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $9.14 to $9.55. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2023-08-15 | M | A | 37,500 | $2.22 | 875,686 | D | — | — | |
| 5 | Common | Class A Common Stock | 2023-08-15 | F | D | 4,727 | $9.19 | 838,186 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-08-16 | M | D | 37,500 | $0.00 | 1,410,135 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F6) The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events. |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-08-15 | M | D | 37,500 | $0.00 | 1,485,135 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F6) The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events. |